2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trialIan Smith, Martine Piccart, A. Feyereislova et al.|The Lancet|2007Cited by 1.5k
Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic AcidMiguel Martín, Ada Braun, Richard H. Bell et al.|Clinical Cancer Research|2012Cited by 145